MCID: TYP003
MIFTS: 12

Type I Ehlers-Danlos Syndrome

Categories: Blood diseases, Bone diseases, Fetal diseases, Genetic diseases, Rare diseases, Skin diseases

Aliases & Classifications for Type I Ehlers-Danlos Syndrome

MalaCards integrated aliases for Type I Ehlers-Danlos Syndrome:

Name: Type I Ehlers-Danlos Syndrome 12
Ehlers-Danlos Syndrome Type 1 44 73
Ehlers-Danlos Syndrome, Type 1 12

Classifications:



External Ids:

Disease Ontology 12 DOID:14720
MeSH 44 C536194
NCIt 50 C125696
SNOMED-CT 68 83470009
UMLS 73 C0268335

Summaries for Type I Ehlers-Danlos Syndrome

MalaCards based summary : Type I Ehlers-Danlos Syndrome, also known as ehlers-danlos syndrome type 1, is related to ehlers-danlos syndrome, classic type, 1. An important gene associated with Type I Ehlers-Danlos Syndrome is COL1A2 (Collagen Type I Alpha 2 Chain). The drugs Clindamycin and Rifampicin have been mentioned in the context of this disorder. Affiliated tissues include skin and bone.

Related Diseases for Type I Ehlers-Danlos Syndrome

Diseases in the Ehlers-Danlos Syndrome family:

Ehlers-Danlos Syndrome, Type V Type I Ehlers-Danlos Syndrome
Autosomal Recessive Type Iv Ehlers-Danlos Syndrome Ehlers-Danlos Syndrome Type 7b

Diseases related to Type I Ehlers-Danlos Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 ehlers-danlos syndrome, classic type, 1 11.6

Symptoms & Phenotypes for Type I Ehlers-Danlos Syndrome

Drugs & Therapeutics for Type I Ehlers-Danlos Syndrome

Drugs for Type I Ehlers-Danlos Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
2
Rifampicin Approved Phase 3 13292-46-1 5458213 5381226
3 Antibiotics, Antitubercular Phase 3
4 Antitubercular Agents Phase 3
5 Clindamycin palmitate Phase 3
6 Clindamycin phosphate Phase 3
7 Anti-Infective Agents Phase 3
8 Anti-Bacterial Agents Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular Catheter Completed NCT00286104 Phase 3

Search NIH Clinical Center for Type I Ehlers-Danlos Syndrome

Cochrane evidence based reviews: ehlers-danlos syndrome type 1

Genetic Tests for Type I Ehlers-Danlos Syndrome

Anatomical Context for Type I Ehlers-Danlos Syndrome

MalaCards organs/tissues related to Type I Ehlers-Danlos Syndrome:

41
Skin, Bone

Publications for Type I Ehlers-Danlos Syndrome

Variations for Type I Ehlers-Danlos Syndrome

Expression for Type I Ehlers-Danlos Syndrome

Search GEO for disease gene expression data for Type I Ehlers-Danlos Syndrome.

Pathways for Type I Ehlers-Danlos Syndrome

GO Terms for Type I Ehlers-Danlos Syndrome

Sources for Type I Ehlers-Danlos Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....